Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. OCTOBER 2019 New or Updated Treatment Guidelines Updated clinical Read More …
Author: marketing@sanfordguide.com
September ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. September 2019 New Antimicrobial Drug Approvals Xenleta (lefamulin*), a Read More …
Sanford Guide Announces Integration with Wise Diagnostic Systems
Sperryville, VA – Sanford Guide® announces the availability of its industry-leading infectious diseases guidelines through lab reports generated by Wise Diagnostic Systems. This new integration, facilitated by Sanford Guide’s content delivery API, links to pertinent Sanford Guide content directly from the report to help guide appropriate antimicrobial selection and dosing. Wise Diagnostic Systems, a Read More …
August ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. August 2019 From CDC Updated recommendations from the CDC Read More …
Sanford Guide Announces Integration with MD Labs
Sperryville, VA – Sanford Guide® announces the availability of its industry-leading infectious diseases guidelines through MD Labs® Results Reports. This new integration, facilitated by Sanford Guide’s content delivery API, links to pertinent Sanford Guide content directly from the report to help guide appropriate antimicrobial selection and dosing. “Interpreting lab results within the context of Read More …
July ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. July 2019 New Antimicrobial Drug Approvals Recarbrio (imipenem/cilastatin/relebactam), approved Read More …
June ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. June 2019 CDC Health Advisory CDC is expecting a 3 Read More …
May ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. May 2019 New Print Editions Now Available Sanford Read More …
April ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. April 2019 Improved Sanford Guide Organization & Features Read More …
March ID Update
Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now. March 2019 New or Updated Treatment Guidelines Updated guidelines Read More …